viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 934
tüüp :
ajaleht
interneti link :
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=452
uurimisrühmad :
Nagoya - Meijo University, Faculty of Pharmacy
Autor :
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.
pealkiri :
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
publikatsioon :
Int J Pharm Compound ; 2: 318-321. 1998
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Cefmenoxime
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Ceftizoxime sodium
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefuzonam
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Moxalactam
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefmenoxime
20 mg/ml
+
1 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
1 mg/ml
+
Ceftizoxime sodium
20 mg/ml
+
1 mg/ml
+
Cefuzonam
20 mg/ml
+
1 mg/ml
+
Moxalactam
20 mg/ml
+
25°C
Ranitidine hydrochloride
0,5 mg/ml
Moxalactam
10 mg/ml
2
25°C
Ranitidine hydrochloride
0,5 mg/ml
Ceftizoxime sodium
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefoperazone sodium
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefmenoxime
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefuzonam
10 mg/ml
4
Mentions Légales
